Alzheimer's - Dementia, Author Interviews / 17.12.2013

MedicalResearch.com Interview with: Lieke Smits drs. L.L. Smits VU University Medical Center Department of Neurology - Alzheimer Center 1081 HV Amsterdam, The Netherlands MedicalResearch.com:  What are the main findings of the study? Answer: In this study we used two visual ratings scales to estimate atrophy of the medial temporal lobe (MTA) and posterior atrophy (PA) on MRI in patients with Alzheimer’s disease. We assessed associations between MTA and PA with cognitive impairment. We found that MTA was associated with worse performance in memory, language and attention, while PA was associated with worse performance in viuso-spatial functioning and executive functioning. Further stratification for age at diagnosis revealed that in late onset (>65 years old) MTA was associated with impairment in memory, language, visuo-spatial functioning and attention. In early onset patients (<65 years old), worse performance on visuo-spatial functioning almost reached significance. (more…)
Author Interviews, Cannabis, Schizophrenia / 16.12.2013

MedicalResearch.com Interview with: Dr. Matthew J. Smith PhD Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, 710 N. Lake Shore Drive, 13th Floor, Abbott Hall, Chicago, IL 60611 MedicalResearch.com: What are the main findings of the study? Dr. Smith: We observed that the shapes of brain structures involved in a working memory brain circuit seemed to collapse inward in a similar fashion among both of the groups that had a history of daily cannabis use. These cannabis-related changes in shape were directly related to the participants’ poor performance on working memory tasks. Some of the shape abnormalities were more severe in the group with schizophrenia and the history of daily cannabis use. We also found that participants with an earlier age of daily cannabis use had more abnormal brain shapes. (more…)
Author Interviews, Brain Injury, Nutrition, Sleep Disorders / 15.12.2013

Miranda M. Lim, MD, PhD Assistant Professor, Sleep Medicine Division of Pulmonary and Critical Care Portland VA Medical Center and Oregon Health & Science UniversityMedicalResearch.com Interview with: Miranda M. Lim, MD, PhD Assistant Professor, Sleep Medicine Division of Pulmonary and Critical Care Portland VA Medical Center and Oregon Health & Science University MedicalResearch.com: What are the main findings of the study? Dr. Lim: People with traumatic brain injury (TBI) often have persistent sleep-wake disturbances including excessive daytime sleepiness and nighttime insomnia, yet the link between a hard blow to the head and drowsiness remains a mystery. We report that a dietary supplement containing branched chain amino acids helps keep mice with TBI awake and alert. The findings suggest that branched chain amino acids, something all humans produce from foods in their normal diets, could potentially alleviate sleep problems associated with TBI. In experiments with brain-injured mice that had trouble staying awake, we found that feeding the animals a dietary supplement enriched with branched chain amino acids improved wakefulness. Treated mice not only stayed continuously awake for longer periods of time, they also showed more orexin neuron activation, neurons known to be involved in maintaining wakefulness. (Previous studies have shown that people with narcolepsy lose significant amounts of orexins.) Branched chain amino acids are the building blocks of neurotransmitters, the chemicals released by neurons in the brain, including glutamate and GABA. We believe that branched chain amino acids act to restore the excitability of orexin neurons after brain injury, which could potentially promote wakefulness. Further studies are needed to pinpoint the exact mechanism of branched chain amino acids effect on sleep pathways in the brain, and to determine any side effects. (more…)
ADHD, Author Interviews, Radiology / 15.12.2013

Dr. Vitria Adisetiyo, Ph.D. Postdoctoral Research Fellow Medical University of South Carolina Center for Biomedical Imaging Charleston, SC 29425MedicalResearch.com Interview with: Dr. Vitria Adisetiyo, Ph.D. Postdoctoral Research Fellow Medical University of South Carolina Center for Biomedical Imaging Charleston, SC 29425 MedicalResearch.com: What are the main findings of the study? Dr. Adisetiyo:  Using a non-invasive MRI method called magnetic field correlation imaging, we detected significantly reduced striatal and thalamic brain iron in medication-naive children and adolescents with ADHD compared to age-, gender- and IQ-matched typically developing controls. ADHD patients who had a history of psychostimulant medication treatment (e.g. Ritalin, Aderrall) had brain iron levels comparable to controls, suggesting brain iron may normalize with psychostimulants. Blood iron measures did not differ between patients and controls. (more…)
ADHD, Author Interviews, Mental Health Research / 15.12.2013

MedicalResearch.com Interview with: Professor Desiree Silva MB BS, FRACP, MPH Consultant Paediatrician Suite 210 Specialist Centre, Joondalup Health Campus 60 Shenton Avenue, Joondalup WA 6027MedicalResearch.com Interview with: Professor Desiree Silva MB BS, FRACP, MPH Consultant Paediatrician Suite 210 Specialist Centre, Joondalup Health Campus 60 Shenton Avenue, Joondalup WA 6027 MedicalResearch.com: What are the main findings of the study? Prof. Silva: Our study is one of the largest population based studies of 12,991 children with ADHD. We found that smoking in pregnancy, maternal urinary infections, preeclampsia, being induced and threatened pre-term labour increases the risk of ADHD with little gender differences.  Prematurity also increased the risk of ADHD including babies born late preterm and early term marginally increased the risk of ADHD. (more…)
Author Interviews, Depression, Education, End of Life Care, JAMA, Stanford / 06.12.2013

J. Randall Curtis, MD, MPH Professor of Medicine Director, UW Palliative Care Center of Excellence Section Head, Pulmonary and Critical Care Medicine, Harborview Medical CenterA. Bruce Montgomery, M.D. – American Lung Association Endowed Chair in Pulmonary and Critical Care Medicine University of Washington, Seattle, WA 98104MedicalResearch.com Interview with: J. Randall Curtis, MD, MPH Professor of Medicine Director, UW Palliative Care Center of Excellence Section Head, Pulmonary and Critical Care Medicine, Harborview Medical CenterA. Bruce Montgomery, M.D. – American Lung Association Endowed Chair in Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA 98104 MedicalResearch.com: What are the main findings of the study? Dr. Curtis: We examined the effect of a communication-skills intervention for internal medicine and nurse practitioner trainees on patient- and family-reported outcomes.  The study was funded by the National Institutes of Nursing Research of the National Institutes of Heatlh.  We conducted a randomized trial with 391 internal medicine and 81 nurse practitioner trainees at two universities.  Participants were randomized to either an 8-session simulation-based, communication-skills intervention or to usual education.  We collected outcome data from a large number of patients with life-limiting illness and their families, including 1866 patient ratings and 936 family ratings.  The primary outcome was patient-reported quality of communication and, overall, this outcome did not change with the intervention.  However, when we restricted our analyses to only patients who reported their own health status as poor, the intervention was associated with increased communication ratings. Much to our surprise, the intervention was associated with a small but significant increase in depression scores among post-intervention patients.  Overall, this study demonstrates that among internal medicine and nurse practitioner trainees, simulation-based communication training compared with usual education improved communication skills acquisition, but did not improve quality of communication about end-of-life care for all patients.  However, the intervention was associated with improved patient ratings of communication for the sickest patients. Furthermore, the intervention was associated with a small increase in patients’ depressive symptoms, and this appeared most marked among patients of the first-year residents. (more…)
Alzheimer's - Dementia, Author Interviews, Nature / 05.12.2013

Alessandra d’Azzo PhD Department of Genetics, St Jude Children’s Research Hospital 262 Danny Thomas Place, Memphis, Tennessee 38105MedicalResearch.com Interview with: Alessandra d’Azzo PhD Department of Genetics, St Jude Children’s Research Hospital 262 Danny Thomas Place, Memphis, Tennessee 38105 MedicalResearch.com: What are the main findings of the study? Dr. d’Azzo: We have discovered a connection between a rare childhood disorder and Alzheimer’s disease that usually affects older people. The culprit is a metabolic enzyme called NEU1 that normally controls the recycling or disposal of proteins in a specific cell compartment, the lysosome. When NEU1 is defective, children develop the severe metabolic disease, sialidosis. Our study suggests that NEU1 also plays an important role in the development of Alzheimer’s disease. Based on this discovery, we decided to increase NEU1 enzyme activity in the brain of an Alzheimer’s disease mouse model that shows features characteristic of the human disease, namely the accumulation of toxic protein aggregates or plaques. Remarkably, we could significantly diminish the number of plaques in the brain of these mice by increasing NEU1 enzyme activity. (more…)
Author Interviews, JAMA, Mental Health Research / 03.12.2013

Ian Kronish, MD, MPHMedicalResearch.com Interview with: Ian Kronish, MD, MPH Assistant Professor of Medicine Center for Behavioral Cardiovascular Health Division of General Medicine Columbia University Medical Center MedicalResearch.com: What are the main findings of the study? Dr. Kronish: Among primary care patients with persistently uncontrolled blood pressure despite medication treatment, we found that medication non-adherence was more than twice as common in patients with PTSD (68%) as compared to patients without PTSD (26%). The association between PTSD and medication non-adherence remained present after adjustment for key covariates including regimen complexity and depression. Recent research shows that PTSD not only contributes to psychological distress, but is also associated with increased risk for incident and recurrent cardiovascular disease. The data from our study suggest that medication non-adherence may be an important mechanism by which PTSD increases risk for cardiovascular disease. (more…)
Author Interviews, Autism, OBGYNE / 01.12.2013

MedicalResearch.com Interview with: Jakob Christensen Department of Neurology, Aarhus University Hospital, Aarhus, Denmark; Merete Juul Sørensen Regional Centre of Child and Adolescent Psychiatry, Aarhus University Hospital Risskov, Denmark MedicalResearch.com: What are the main findings of the study? Answer: We found that the risk of autism spectrum disorder was increased by 50% in children of mothers who took antidepressants during pregnancy. However, when we controlled for other factors related to the medication, by comparing with children of mothers with a diagnosis of depression or with un-exposed siblings, the risk was smaller and not significantly increased. (more…)
Author Interviews, Autism, McGill, Pediatrics / 25.11.2013

Dr. Michael Shevell Chair of the Pediatrics Department at the McGill Faculty of Medicine and Pediatrician-in-Chief at the Montreal Children’s Hospital and the McGill University Health CentreMedicalResearch.com Interview Dr. Michael Shevell Chair of the Pediatrics Department at the McGill Faculty of Medicine and Pediatrician-in-Chief at the Montreal Children’s Hospital and the McGill University Health Centre MedicalResearch.com: What are the main findings of the study? Dr. Shevell: At risk term infants who have spent some time in a Level III NICU after birth are at substantially increased later risk for an autistic spectrum disorder. Frequently this disorder occurs in conjunction with substantial co-morbidity. (more…)
Author Interviews, Cognitive Issues, Erasmus, Statins / 25.11.2013

Prof Ype Elgersma PhD Professor, Neuroscience Neuroscience Institute, Erasmus University Rotterdam Rotterdam, NetherlandsMedicalResearch.com Interview with: Prof Ype Elgersma PhD Professor, Neuroscience Neuroscience Institute, Erasmus University Rotterdam Rotterdam, Netherlands MedicalResearch.com: What are the main findings of the study? Answer: Research in genetic mouse models suggested that inhibition of HMG-CoA-reductase by statins might ameliorate the cognitive and behavioral phenotype of children with Neurofibromatosis type 1 (NF1), an autosomal dominant disorder. In a 12-month randomized placebo-controlled study including 84 children with NF1, we found that simvastatin, an inhibitor of the HMG-CoA-reductase pathway had no effect on full-scale intelligence, attention problems or internalizing behavioral problems, or on any of the secondary outcome measures. (more…)
Author Interviews, Depression, General Medicine, PLoS / 25.11.2013

Alize J. Ferrari University of Queensland School of Population Health Herston, Queensland, AustraliaMedicalResearch.com Interview with: Alize J. Ferrari University of Queensland School of Population Health Herston, Queensland, Australia MedicalResearch.com: What are the main findings of the study? Answer: In our paper recently published in PloS Medicine, we report findings from the Global Burden of Disease Study 2010 for depression. We found that depression (defined as major depressive disorder and dysthymia) accounted fr 8% of the non fatal burden in 2010, making it the second leading cause of disability worldwide. Burden due to depression increased by 35% between 1990 and 2010, although this increase was entirely driven by population growth and ageing. Burden occurred across the entire lifespan, was higher in females compared to males, and there were differences between world regions.When depression was considered a risk factor for other health outcomes it explained 46% of the burden allocated to suicide and 3% of the burden allocated ischemic heart disease. (more…)
Author Interviews, Cognitive Issues / 24.11.2013

Dr. Soo Borson, M.D. Professor Department of Psychiatry and Behavioral Sciences, University of Washington School of MedicineMedicalResearch.com Interview with: Dr. Soo Borson, M.D. Professor Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine   MedicalResearch.com: What are the main findings of the study? Dr. Borson:  We developed a new short screen to help clinicians and health care systems identify dementia patients and their caregivers who have unmet needs for dementia care services - extra help from primary care providers or clinical specialists skilled in understanding and managing problems related to dementia, working with caregivers to alleviate stress and burden, and locating community-based support services. (more…)
Alzheimer's - Dementia, Author Interviews, Blood Pressure - Hypertension / 23.11.2013

MedicalResearch.com Interview with: Dan Nation Assistant Professor, Department of Psychology at University of Southern California Veterans Affairs San Diego Healthcare System MedicalResearch.com: What are the main findings of the study? Answer:   The main study findings indicate that high blood pressure, specifically pulse pressure (systolic - diastolic pressure), is associated with increased markers of Alzheimer's disease in the cerebral spinal fluid of healthy middle-aged adults.  These results suggest a connection between blood pressure and Alzheimer's disease prior to the onset of any symptoms of the disease. (more…)
Author Interviews, Brain Injury / 23.11.2013

Dr. Andrew R. Mayer, PhD The Mind Research Network Lovelace Biomedical and Environmental Research InstituteMedicalResearch.com Interview with: Dr. Andrew R.  Mayer, PhD The Mind Research Network Lovelace Biomedical and Environmental Research Institute   MedicalResearch.com: What are the main findings of the study? Dr. Mayer: a)     Just because mTBI patients self-report reduced and/or no post-concussive symptoms does not mean that they have completed the healing process. b)     Current gold-standards in the clinical world (CT scans and self-report) may not be accurately capturing brain health after injury. c)     Diffusion imaging shows promise for being a more sensitive biomarker for measuring recovery than currently used techniques. (more…)
Author Interviews, Cognitive Issues, Mediterranean Diet / 22.11.2013

samantha_gardenerMedicalResearch.com: Samantha Gardener PhD Student Senior Research Assistant for DIAN and AIBL Studies McCusker Alzheimer's Research Foundation 2/142 Stirling Hwy 
NEDLANDS 6009
Western Australia MedicalResearch.com: What are the main findings of your study? Answer: Our research indicates that consuming larger quantities of foods included in a western dietary pattern is associated with greater cognitive decline in visuospatial functioning after 36 months. Foods included in the western dietary pattern are red and processed meats, high fat dairy products, chips, refined grains, potatoes, sweets and condiments. Visuospatial functioning is an area which includes distance and depth perception, reproducing drawings and using components to construct objects or shapes. In contrast, adherence to the Mediterranean diet, a healthy eating pattern is associated with less decline in executive function. Foods included in the Mediterranean diet are vegetables, fruits and fish. Examples of executive function include planning and organising, problem solving and time management. (more…)
Author Interviews, Cost of Health Care, Mental Health Research / 18.11.2013

Dr. Abigail Powers PhD Clinical Psychology Postdoctoral Fellow Emory University School of Medicine MedicalResearch.com: What are the main findings of the study? Dr. Powers: Personality disorders (i.e., problematic personality patterns that cause significant distress and dysfunction in individuals’ lives across many areas of functioning) are associated with many negative health outcomes in young adulthood. The goal of this research study was to determine the relationship between personality pathology and medical resource utilization as individuals age and develop new physical health problems.  Among community-dwelling later middle-aged adults (ages 55-64), we found that personality pathology was related to higher reported medical resource utilization (including doctor visits, hospitalizations, and number of outpatient procedures) independent of health status. Of the 10 DSM-IV personality disorders assessed, narcissistic and antisocial personality disorder features were associated with greater medical resource utilization independent of the presence of physical health problems. Also, among individuals with a greater number of physical health problems, histrionic and dependent personality disorder features were related to greater medical resource utilization, suggesting that important interactions between personality pathology and health conditions may occur in older age and impact resource use. (more…)
Author Interviews, Health Care Systems, Long Term Care, Mental Health Research / 16.11.2013

Hugh C. Hendrie, MB ChB, DSc Professor, Department of Psychiatry, Indiana University School of Medicine Center Scientist, Indiana University Center for Aging Research Research Scientist, Regenstrief Institute, Inc.MedicalResearch.com Interview with: Hugh C. Hendrie, MB ChB, DSc  Professor, Department of Psychiatry, Indiana University School of Medicine Center Scientist, Indiana University Center for Aging Research Research Scientist, Regenstrief Institute, Inc. MedicalResearch.com: What are the main findings of the study? Answer: Our findings of higher rates of emergency care, longer hospitalizations and increased frequency of falls, substance abuse and alcoholism suggest that seriously mentally ill older adults remain a vulnerable population. (more…)
Author Interviews, Brain Injury, Cognitive Issues, Lancet / 12.11.2013

prof_david_menonMedicalResearch.com Interview with: Prof David K Menon MD PhD FRCP FRCA FFICM FMedSci Head, Division of Anaesthesia, University of Cambridge 
Consultant, Neurosciences Critical Care Unit 
BOC Professor, Royal College of Anaesthetists Professorial Fellow, Queens' College, Cambridge Senior Investigator, National Institute for Health Research Box 93, Addenbrooke's Hospital, 
Cambridge CB2 2QQ, UK MedicalResearch.com: What is the background for your study? Dr. Menon: We have known for some time that a history of traumatic brain injury (TBI) results in a significant (between 2 and 10 fold) increase in the likelihood of getting dementia in later life.  On possible mechanistic explanation for this comes from the finding that about a third of individuals who died of TBI, regardless of age, are found at autopsy to have deposits of β-amyloid in the brain, often Aβ42, which is the same variant of amyloid seen in the brain of patients who have Alzheimer’s Disease. However, such detection after death has made it impossible to examine the linkage of such early amyloid deposition to late dementia.  More recently, imaging with positron emission tomography (PET) and Pittsburgh compound B (PIB) has been used to image amyloid deposits in Alzheimer’s  Disease.  However, the technique had not been validated in traumatic brain injury. (more…)
Author Interviews, Depression, JAMA / 07.11.2013

Richard L. Kravitz, MD, MSPH Professor and Co-vice Chair (Research) Interim Director, UC Center Sacramento Co-Editor in Chief, Journal of General Internal MedicineMedicalResearch.com Interview with: Richard L. Kravitz, MD, MSPH Professor and Co-vice Chair (Research) Interim Director, UC Center Sacramento Co-Editor in Chief, Journal of General Internal Medicine MedicalResearch.com: What is the background for your study? Dr. Kravitz: Depression in the United States is both undertreated and overtreated.  As the de facto mental health care system for many, primary care is at the nexus of this problem.  Up to 30% of patients with major depression in primary care go undiagnosed.  At the same time, partly as a result of marketing, lots of patients who don’t need meds are started on antidepressants.   So we were interested in finding ways to get more truly depressed patients into treatment without overtreating patients who don’t need it. (more…)
Author Interviews, Autism, Genetic Research / 30.10.2013

Linda Brzustowicz, M.D. Professor and Chair Department of Genetics Rutgers University Piscataway, NJ 08854MedicalResearch.com Interview with: Linda Brzustowicz, M.D. Professor and Chair Department of Genetics Rutgers University,Piscataway, NJ 08854 MedicalResearch.com: What are the main findings of the study? Dr. Brzustowicz: The objective of this study was to search for locations in the human genome that impact language ability in individuals with autism as well as in their family members without autism.  To do this, we recruited families with an individual with autism and at least one other family member without autism but with a language learning impairment.  We identified two locations in the human genome that are linked to language ability in these families.  Importantly, these locations do not appear to be specific to language impairment in the individuals with autism, but are related to language ability in other family members as well.  This suggests that while individuals with autism may have new, or de novo, genetic variations that are important for risk of illness, they may also carry inherited genetic variation that influence the expression of their illness.  The effects of these inherited variants can also be seen in the language performance of family members without autism. (more…)
Author Interviews, Diabetes, Mediterranean Diet, Memory / 24.10.2013

MedicalResearch.com Interview with: Lucia Kerti MA From the Departments of Neurology Charité–University Medicine, Berlin MedicalResearch.com: What are the main findings of the study? Answer: The results of our study on 141 healthy older people suggest that chronically higher blood glucose levels may have a negative influence on memory performance even in the absence of type 2 diabetes or even pre-diabetes. Moreover, our findings indicate that elevated blood glucose levels  impair the functioning of brain areas like the hippocampus, a structure particularly relevant for memory. An important novel aspect in our study was the additional analysis of diffusion tensor imaging-based mean diffusivity within the hippocampal, which allowed us to  obtain information on microstructure.  We here provided first-time data of an association between higher blood glucose levels and lower hippocampal microstructure. Decreased hippocampal microstructure as measured by mean diffusivity may reflect a disruption of neuronal membranes and increased extracellular water content, leading to decreased signaling within and between hippocampal cells. Thus, information transfer between cells, indispensable for memory encoding, storage and retrieval, would be compromised. In sum, our data suggest that chronically higher blood glucose levels even within the "normal range" may decrease memory functions, possibly in part mediated by microstructural changes within the hippocampus. (more…)
Alzheimer's - Dementia, Author Interviews / 24.10.2013

MedicalResearch.com Interview with: Andrew S. Lim MD MMSc FRCPC DABPN Assistant Professor and Clinician Scientist Division of Neurology, Department of Medicine Sunnybrook Health Sciences Centre University of Toronto MedicalResearch.com: What are the main findings of the study? Dr. Lim: Alzheimer disease (AD) is the result of a confluence of genetic, behavioral, and environmental risk factors.  The Apolipoprotein E (APOE) e4 allele is the most common and well established genetic risk factor for Alzheimer Disease.  10-20% of the US population carries the high risk APOE e4 allele, which confers up to a 30% lifetime risk of AD. Meanwhile, previous work had suggested that poor sleep may be a risk factor for AD and that APOE genotype and poor sleep may amplify each other's negative cognitive effects. We asked the question whether good sleep consolidation (i.e. sound sleep without repeated awakenings) may reduce the effect of APOE on the risk of incident AD and the burden of AD pathology.  We studied 698 individuals without dementia participating in the Rush Memory and Aging Project - a longitudinal cohort study of aging and risk factors for AD.  We measured sleep consolidation using wrist-watch like devices called actigraphs, and followed participants for up to 6 years, examining them annually for the development of AD.  Autopsies were perfumed on 201 participants who died during the follow-up period and we quantified the burden of AD pathology. During the follow-up period, 98 participants developed AD.  As expected, carrying the APOE e4 allele was associated with a higher risk of AD, faster cognitive decline, and a higher burden of AD pathology (amyloid plaques and neurofibrillary tangles) at death. However, better sleep at baseline significantly reduced the negative impact of APOE e4 on the risk of AD, rate of cognitive decline, and burden of neurofibrillary tangle pathology. (more…)
Author Interviews, BMJ, Compliance, Mental Health Research / 18.10.2013

Professor Stefan Priebe, Dipl.-Psych., Dr. med. habil., FRCPsych Unit for Social and Community Psychiatry WHO Collaborating Centre for Mental Health Services Development Queen Mary, University of LondonMedicalResearch.com Interview with Professor Stefan Priebe, Dipl.-Psych., Dr. med. habil., FRCPsych Unit for Social and Community Psychiatry WHO Collaborating Centre for Mental Health Services Development Queen Mary, University of London MedicalResearch.com: What are the main findings of the study? Answer: Offering modest financial incentives can help patients to achieve better adherence to anti-psychotic maintenance medication.  (more…)
Author Interviews, Mental Health Research, Nature / 18.10.2013

kees_jan_kanMedicalResearch.com Interview with Dr. Kees-Jan Kan PhD Department of Biological Psychology, VU University Department of Psychological Methods, University of Amsterdam MedicalResearch.com: What are the main findings of the study? Answer: We asked ourselves how well theories of intelligence actually predict empirical results. To this end, we reviewed and scrutinized the predictions from intelligence theories and collected relevant results that have been published in the scientific literature over the last decades. The results pertained to intelligence test scores from thousands of subjects across the world. We found that on essential aspects the empirical results were opposite of the predictions from the mainstream theories of intelligence, in which intelligence is interpreted as a biological trait. (more…)
Author Interviews, Eating Disorders, Weight Research / 17.10.2013

MedicalResearch.com Interview with Stephan  Zipfel  MD Professor of Medicine & Dean of Medical Education Head Department of Internal Medicine VI (Psychosomatic Medicine and Psychotherapy) University Medical Hospital Tuebingen President of the German College of Psychosomatic Medicine (DKPM) Co-Director of the centre for nutritional Medicine Tuebingen-Hohenheim 72076 Tuebingen / Germany MedicalResearch.com: What are the main findings of the study? Prof. Zipfel: Outpatient treatment of adults with anorexia nervosa by either enhanced cognitive-behaviour therapy, focal psychodynamic therapy, or optimised treatment as usual led to relevant weight gains and a decrease in general and eating disorder-specific psychopathology during the course of treatment. These positive effects continued beyond treatment until 12-month follow-up. Most patients completed treatment and the acceptance of both specific therapy approaches was high among both patients and therapists. (more…)
Aging, Author Interviews, Memory / 11.10.2013

Prof. Timothy Salthouse Brown-Forman Professor of Psychology Department of Psychology University of Virginia Charlottesville, VA 22904-4400MedicalResearch.com Interview with: Prof. Timothy Salthouse Brown-Forman Professor of Psychology Department of Psychology University of Virginia Charlottesville, VA 22904-4400 MedicalResearch.com: What prompted this work? Prof. Salthouse: I think it is noteworthy that the research originated as an undergraduate project by Arielle Mandell. Ms. Mandell was supported by a University of Virginia Harrison Undergraduate Research Award while she was doing the research, and a report of the research served as her Distinguished Major Thesis. The research was prompted by the observation that according to self-reports, tip-of-the-tongue experiences occur more and more frequently with increased age, and often seem to be associated with concerns about memory decline and possibly impending dementia. We wondered
  1. 1) whether these self-reports are valid, and
  2. 2) if they are valid, do they truly indicate age-related failures of the type of memory used in the diagnosis of dementia.
(more…)
Author Interviews, Cognitive Issues, Genetic Research, Memory / 11.10.2013

Dr. Rebecca Todd Assistant Professor University of British Columbia Department of Psychology Centre for Interactive Research on Sustainability 4342A-2260 West Mall Vancouver, BC V6T 1Z4MedicalResearch.com Interview with: Dr. Rebecca Todd Assistant Professor University of British Columbia Department of Psychology Centre for Interactive Research on Sustainability 4342A-2260 West Mall Vancouver, BC V6T 1Z4 MedicalResearch.com: What are the main findings of the study? Answer: What we found, in essence, is that some individuals are genetically predisposed to see the world more darkly than others. We find that a common gene variant is linked to perceiving emotional events --especially negative ones --¬ more vividly than others. This gene variant has been previously linked (by other researchers) to emotional memory and the likelihood of experiencing intrusive, or “flashback” memories following traumatic experience. Our findings suggest that in healthy young adults this enhanced emotional memory may be because individuals are more likely to perceive what’s emotionally relevant in the first place. We've all heard of rose colored glasses, but this is more like gene-colored glasses, tinted a bit darkly. (more…)
Author Interviews, Cancer Research, Mental Health Research, Pediatrics, Social Issues / 09.10.2013

Dr. Elisabeth Jeppesen MPH, PhD-fellow National Resource Center for Late Effects after Cancer Treatment, Department of Oncology, Oslo University, Hospital, The Norwegian Radiumhospitalet, OslMedicalResearch.com Interview with: Dr. Elisabeth Jeppesen MPH, PhD-fellow National Resource Center for Late Effects after Cancer Treatment, Department of Oncology, Oslo University, Hospital, The Norwegian Radiumhospitalet, Oslo, Norway mobil +47 951 05271 
Wisit: Ullernchaussen 70 (Radiumhospitalet) www.oslo-universitetssykehus.no MedicalResearch.com: What is the background of this study? Answer: Each year a considerable number of parents with children younger than 18 years of age are affected by cancer in a parent. Cancer in one of the parents might represent a potentially traumatic event and thereby may be a risk factor for psychosocial problems in the offspring. So far, teenagers’ psychosocial responses to parental cancer have only been studied to a limited extent in controlled trials. Using a trauma theory perspective many studies have shown significant direct associations between parental cancer and psychosocial problems in teenagers. However, the literature also indicates that most children and teenagers have normal stress reactions to such events. In order to identify the need for eventual prevention and intervention among teenagers exposed to such a stressor, we need more empirical knowledge of their psychosocial situation. (more…)
Author Interviews, Cognitive Issues, Johns Hopkins, Mental Health Research / 07.10.2013

MedicalResearch.com Interview with: Dr. Seth S. Martin, MD Division of Cardiology, Johns Hopkins Hospital 600 North Wolfe Street Baltimore, Maryland 21287 Johns Hopkins Hospital Baltimore, MD 21287. MedicalResearch.com: What are the main findings of the study? Dr. Martin: Our systematic review identified 16 studies for qualitative synthesis and 11 for quantitative synthesis. In individuals without baseline cognitive dysfunction, statins did not adversely affect memory when used in the short-term (<1 year). Long-term cognition studies including 23,433 patients with a mean exposure duration of 3 to 24.9 years showed a 29% relative reduction in incident dementia related to statin use (hazard ratio, 0.71; 95% CI 0.61-0.82) and a 2% absolute risk reduction (number needed to treat for 6.2 years: 50). (more…)